Recorded parent voice for newborns with opioid withdrawal
Part of Genetic & congenital, Mental health clinical trials.
This study tests whether playing a recording of a parent's or caregiver's voice can help calm and comfort newborns who are withdrawing from opioids they were exposed to before birth. If it works, it might reduce the need for stronger medicines and help babies recover more comfortably.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is being cared for at HSC Women's Hospital or St. Boniface Hospital
- Your baby was exposed to opioids before birth and is showing signs of withdrawal (called neonatal opioid withdrawal syndrome, or NOWS)
- Your baby is being treated using an approach called 'Eat, Sleep, Console'
- Your baby needs care in the neonatal intensive care unit (NICU) or extra medical care for ongoing withdrawal management
- You or another caregiver can provide a voice recording (in any language) and give permission for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different medicine approaches to treat newborns with opioid withdrawal (NOWS). It compares how well babies do with standard care and may help find the best way to manage symptoms and support recovery.
This program helps participating hospitals improve care for newborns who may go through opioid withdrawal (also called neonatal abstinence syndrome). It mainly aims to make mother-baby support and treatment plans work better after delivery.
This study looks at tiny genetic signals (microRNA) in newborn samples to identify neonatal opioid withdrawal syndrome. It may help doctors recognize withdrawal sooner, so babies can get the right care faster.
This study looks at how opioid exposure during pregnancy affects blood flow and brain function in newborns. Researchers will compare babies exposed to opioids in the womb with babies who were not exposed, to better understand how prenatal opioid exposure affects the developing brain.
This study aims to improve care for mothers with opioid use disorder and their babies with neonatal abstinence syndrome. Researchers will interview healthcare providers and mothers to develop better support programs.
This study is collecting information from two groups of newborns: those with Neonatal Abstinence Syndrome (NAS, caused by drug exposure before birth) and healthy newborns. The goal is to see if an automated system makes it easier to gather data without extra tests or procedures.
Hear when a new Neonatal Opioid Withdrawal Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.